These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25168369)

  • 1. Serum Helicobacter pylori CagA antibody may not be used as a tumor marker for diagnosing gastric cancer in east Asian countries.
    Zhao Z; Li Y; Liu S; Fu W
    Tumour Biol; 2014 Dec; 35(12):12217-24. PubMed ID: 25168369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Helicobacter pylori CagA antibody as a biomarker for gastric cancer in east-Asian countries.
    Shiota S; Matsunari O; Watada M; Yamaoka Y
    Future Microbiol; 2010 Dec; 5(12):1885-93. PubMed ID: 21155667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Helicobacter pylori KatA and AhpC antibodies as novel biomarkers for gastric cancer.
    Zhang B; Li HL; Fan Q; Guo F; Ren XY; Zhou HB; Zhu JW; Zhao YS; Tian WJ
    World J Gastroenterol; 2016 Jun; 22(21):5060-7. PubMed ID: 27275098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Helicobacter pylori FliD antibody and the risk of gastric cancer.
    Li H; Zhang B; Hu X; Dong Y; Fan Q; Guo F; Ren X; Zhou H; Tian W; Zhao Y
    Oncotarget; 2016 Apr; 7(16):22397-408. PubMed ID: 26968951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between pork consumption, CagA status and IL-1B-31 genotypes in gastric cancer.
    Wang XQ; Terry PD; Cheng L; Yan H; Wang JS; Wu WA; Hu SK
    World J Gastroenterol; 2014 Jul; 20(25):8151-7. PubMed ID: 25009387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG2 response and low IgG titre specific to Helicobacter pylori CagA as serological markers for gastric cancer.
    de la Cruz-Herrera CF; Flores-Luna L; Gutierrez-Xicotencatl L; Chihu-Amparan L; Sánchez-Aleman MA; Lazcano-Ponce E; Torres J; Ayala G
    J Med Microbiol; 2013 Apr; 62(Pt 4):591-598. PubMed ID: 23288428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Helicobacter pylori CagA antibody titer as a useful marker for advanced inflammation in the stomach in Japan.
    Shiota S; Murakami K; Okimoto T; Kodama M; Yamaoka Y
    J Gastroenterol Hepatol; 2014 Jan; 29(1):67-73. PubMed ID: 24033876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a novel Helicobacter pylori East Asian-type CagA ELISA for detecting patients infected with various cagA genotypes.
    Doohan D; Miftahussurur M; Matsuo Y; Kido Y; Akada J; Matsuhisa T; Yee TT; Htet K; Aftab H; Vilaichone RK; Mahachai V; Ratanachu-Ek T; Tshering L; Waskito LA; Fauzia KA; Uchida T; Syam AF; Rezkitha YAA; Yamaoka Y
    Med Microbiol Immunol; 2020 Feb; 209(1):29-40. PubMed ID: 31549252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology.
    Song H; Michel A; Nyrén O; Ekström AM; Pawlita M; Ye W
    Int J Cancer; 2014 Jun; 134(12):2942-50. PubMed ID: 24259284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of
    Fernandez-Botran R; Wellmann IA; Une C; Méndez-Chacón E; Hernández de Rodas E; Bhandari B; Villagrán de Tercero CI
    Am J Trop Med Hyg; 2020 Jul; 103(1):260-265. PubMed ID: 32314688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of CagA-positive infection with Helicobacter pylori antibodies of IgA class.
    Rautelin HI; Oksanen AM; Karttunen RA; Seppälä KM; Virtamo JR; Aromaa AJ; Kosunen TU
    Ann Med; 2000 Dec; 32(9):652-6. PubMed ID: 11209973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.
    Parsonnet J; Friedman GD; Orentreich N; Vogelman H
    Gut; 1997 Mar; 40(3):297-301. PubMed ID: 9135515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel CagA ELISA exhibits enhanced sensitivity of
    Matsuo Y; Kido Y; Akada J; Shiota S; Binh TT; Trang TT; Dung HD; Tung PH; Tri TD; Thuan NP; Tam LQ; Nam BC; Khien VV; Yamaoka Y
    World J Gastroenterol; 2017 Jan; 23(1):48-59. PubMed ID: 28104980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori blood biomarker for gastric cancer risk in East Asia.
    Cai H; Ye F; Michel A; Murphy G; Sasazuki S; Taylor PR; Qiao YL; Park SK; Yoo KY; Jee SH; Cho ER; Kim J; Chen SC; Abnet CC; Tsugane S; Cai Q; Shu XO; Zheng W; Pawlita M; Epplein M
    Int J Epidemiol; 2016 Jun; 45(3):774-81. PubMed ID: 27170766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel diagnostic monoclonal antibody specific for Helicobacter pylori CagA of East Asian type.
    Yasuda A; Uchida T; Nguyen LT; Kawazato H; Tanigawa M; Murakami K; Kishida T; Fujioka T; Moriyama M
    APMIS; 2009 Dec; 117(12):893-9. PubMed ID: 20078554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori and CagA status, serum gastrin, interleukin-8 and gastric acid secretion in gastric cancer.
    Konturek SJ; Starzynska T; Konturek PC; Karczewska E; Marlicz K; Lawniczak M; Jaroszewicz-Heigelman H; Bielanski W; Hartwich A; Ziemniak A; Hahn EG
    Scand J Gastroenterol; 2002 Aug; 37(8):891-8. PubMed ID: 12229962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori infection and markers of gastric cancer risk in Alaska Native persons: a retrospective case-control study.
    Keck JW; Miernyk KM; Bulkow LR; Kelly JJ; McMahon BJ; Sacco F; Hennessy TW; Bruce MG
    Can J Gastroenterol Hepatol; 2014 Jun; 28(6):305-10. PubMed ID: 24945184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of high-sensitivity C-reactive protein (hs-CRP)in Helicobacter pylori-infected peptic ulcer patients and its association with bacterial CagA virulence factor.
    Jafarzadeh A; Hassanshahi GH; Nemati M
    Dig Dis Sci; 2009 Dec; 54(12):2612-6. PubMed ID: 19160050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study.
    Palli D; Masala G; Del Giudice G; Plebani M; Basso D; Berti D; Numans ME; Ceroti M; Peeters PH; Bueno de Mesquita HB; Buchner FL; Clavel-Chapelon F; Boutron-Ruault MC; Krogh V; Saieva C; Vineis P; Panico S; Tumino R; Nyrén O; Simán H; Berglund G; Hallmans G; Sanchez MJ; Larrãnaga N; Barricarte A; Navarro C; Quiros JR; Key T; Allen N; Bingham S; Khaw KT; Boeing H; Weikert C; Linseisen J; Nagel G; Overvad K; Thomsen RW; Tjonneland A; Olsen A; Trichoupoulou A; Trichopoulos D; Arvaniti A; Pera G; Kaaks R; Jenab M; Ferrari P; Nesi G; Carneiro F; Riboli E; Gonzalez CA
    Int J Cancer; 2007 Feb; 120(4):859-67. PubMed ID: 17131317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum antibody against Helicobacter pylori FlaA and risk of gastric cancer.
    Tian W; Jia Y; Yuan K; Huang L; Nadolny C; Dong X; Ren X; Liu J
    Helicobacter; 2014 Feb; 19(1):9-16. PubMed ID: 24118166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.